This trial develops a process for uploading home blood pressure measurements from a wireless blood pressure monitor called QardioArm directly into the electronic medical record of cancer patients with hypertension and also develops an automated messaging system through patients' electronic medical record for blood pressure management using the home blood pressure measurements. Monitoring patients' blood pressure at home may provide early detection of high blood pressure, with the potential to improve patients' health. Using the wireless monitor and automated messaging system may make it easier for patients to communicate with their primary care provider and oncologist about their blood pressure.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03919214.
PRIMARY OBJECTIVES:
I. Develop and implement a Blood Pressure Management Clinical Pathway for Cancer Patients and Survivors utilizing an automated Maestro messaging system.
Ia. Develop and implement the uploading process for blood pressure measurements every other day (at least 2 morning measurements and 1 evening measurement per week) with an automated quality control.
Ib. Develop and implement the automated messaging system for blood pressure management.
Ic. Determine the proportion of participants whose blood pressure is within an acceptable range at week 12, as per the 2017 American College of Cardiology/American Heart Association (ACC / AHA) guideline.
Id. Determine the patient and provider (primary care provider [PCP] and oncologist) acceptability of the clinical pathway.
OUTLINE:
PHASE I: Patients obtain separate blood pressure measurements using the QardioArm device every other day (at least 2 morning, 1 evening) weekly for 4 weeks.
PHASE II: Patients obtain separate blood pressure measurements using the QardioArm device every other day (at least 2 morning, 1 evening) weekly for 8 weeks and receive automated Duke MyChart messages if triggered by their blood pressure measurements.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationDuke University Medical Center
Principal InvestigatorKevin Charles Oeffinger
